One of the latest reviews on this topic concluded that in the absence of deleterious side effects from GM-CSF administration in sepsis patients, multiple clinical benefits such as rapid recovery from infection, reduced length of hospital stay and decreased need for mechanical ventilation were seen43. This evidence concerns the gene CSF2 and infection.